Aortic Aneurysm Market Trends

Aortic Aneurysm Market size was valued at USD 5.1 Billion in 2023 and is poised to grow from USD 5.53 Billion in 2024 to USD 10.65 Billion by 2032, growing at a CAGR of 8.52% during the forecast period (2025-2032).

A majority of mid- and small-sized businesses dominate this somewhat fragmented industry. The majority of players use mergers and acquisitions as one of their primary methods to improve their position. As an illustration, Terumo Corporation purchased Aortica Corporation, a company based in the United States that is committed to furthering the science of individualized vascular therapy. When performing fenestrated intravascular aortic repair (FEVAR), Aortic a has created Aorta Fit, an automated case planning programme that precisely aligns the opening on the endograft to the particular position of each patient's branch artery. 'Medtronic PLC', 'Cook Medical', 'Terumo Corporation', 'Lombard Medical (MicroPort Scientific Corporation)', 'W. L. Gore & Associates, Inc.', 'Endologix, Inc.', 'Cardinal Health, Inc.', 'C. R. Bard, Inc. (Becton, Dickinson and Company)', 'Bolton Medical (Vascutek Ltd.)', 'JOTEC GmbH', 'Merit Medical Systems, Inc.', 'MicroPort Scientific Corporation', 'CryoLife, Inc.', 'Lemaitre Vascular, Inc.', 'Endospan Ltd.', 'Japan Lifeline Co., Ltd.', 'Getinge AB', 'Altura Medical (Cardinal Health)', 'BiFlow Medical Ltd.', 'LeMaitre Vascular, Inc.'

The rising incidence of aortic aneurysms, particularly in aging populations, is a significant driver for market growth. Factors such as hypertension, smoking, and atherosclerosis contribute to the increasing prevalence of aortic aneurysms, necessitating effective diagnosis and treatment options.

E-commerce Boom: The rapid growth of e-commerce continues to reshape retail markets globally. The convenience, wide product selection, and competitive pricing offered by online platforms have led to a significant shift in consumer behavior, driving the expansion of the e-commerce market.

North America held the largest revenue share of nearly 56.6% in 2023 as a result of the quick advancement of technology, the shift towards procedures that are minimally invasive, and the rising prevalence of AA. The test Stomach Aortic Aneurysms Very Efficiently (SAVE) Act, that has been put into action by the U.S. government in 2014, grants one free AAA test to men who have smoked at least once in their entire lives and women with a family record of the condition. Additionally, the governments' considerable financial assistance is encouraging growth in markets in general. For example, Medicare in the US will pay for one abdominal aorta ultrasound for patients that are at risk.